LCTX Stock Posts

$LCTX negative imbalance of -67 K option volume delta...indicating traderes are more bearish on the stock

Lineage Cell Therapeutics will report earnings after the market closes. View Calendar The market is expecting a ±14.0% move after earnings are reported. The average move for the past 4 quarters of earnings has been ±1.7%. View Expected Move (Conf Call: Mar 5 4:30 PM)

Lineage Cell Therapeutics will report earnings after the market closes. View Calendar The market is expecting a ±14.6% move after earnings are reported. The average move for the past 4 quarters of earnings has been ±1.8%. View Expected Move (Conf Call: Nov 6 4:30 PM)

Lineage Cell Therapeutics will report earnings after the market closes. View Calendar The market is expecting a ±6.8% move after earnings are reported. The average move for the past 4 quarters of earnings has been ±1.9%. View Expected Move (Conf Call: Aug 12 4:30 PM)

Lineage Cell Therapeutics trades 2,819 contracts. The company has the following event: 3rd Annual Spinal Cord Injury Investor Symposium on Jun 27, 2025. News: OpRegen (RG6501) 36-Month Visual Acuity Results Featured at Clinical Trials at the Summit 2025